These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

249 related items for PubMed ID: 20006470

  • 1. In vitro drug susceptibility of 2275 clinical non-tuberculous Mycobacterium isolates of 49 species in The Netherlands.
    van Ingen J, van der Laan T, Dekhuijzen R, Boeree M, van Soolingen D.
    Int J Antimicrob Agents; 2010 Feb; 35(2):169-73. PubMed ID: 20006470
    [Abstract] [Full Text] [Related]

  • 2. Drug susceptibility testing and pharmacokinetics question current treatment regimens in Mycobacterium simiae complex disease.
    van Ingen J, Totten SE, Heifets LB, Boeree MJ, Daley CL.
    Int J Antimicrob Agents; 2012 Feb; 39(2):173-6. PubMed ID: 22099521
    [Abstract] [Full Text] [Related]

  • 3. [Combination of gentamycin and amikacin with rifampicin, ethambutol and isoniazid on selected standard strains of Mycobacterium species in experiments done in vitro and in vivo].
    Janowiec M, Andrzejczyk Z, Marczewska J.
    Pneumonol Pol; 1989 May; 57(5):300-7. PubMed ID: 2633149
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The relationship between the in vitro drug susceptibility of opportunist mycobacteria and their in vivo response to treatment.
    Heginbothom ML.
    Int J Tuberc Lung Dis; 2001 Jun; 5(6):539-45. PubMed ID: 11409581
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. In vitro antimicrobial susceptibility testing of rapidly growing mycobacteria using the tablet diffusion method: resistance pattern of Norwegian Mycobacterium fortuitum and Mycobacterium chelonae isolates.
    Hoel T, Casals JB, Eng J.
    APMIS; 1993 Jan; 101(1):27-32. PubMed ID: 8457323
    [Abstract] [Full Text] [Related]

  • 12. [Testing Mycobacterium tuberculosis for drug sensitivity using different methods].
    Skriagina EM, Zalutskaia OM, Roth A, Mauch H, Nikolenko EN.
    Probl Tuberk; 2001 Jan; (5):43-5. PubMed ID: 11588962
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of microplate Alamar blue assay for drug susceptibility testing of Mycobacterium avium complex isolates.
    Vanitha JD, Paramasivan CN.
    Diagn Microbiol Infect Dis; 2004 Jul; 49(3):179-82. PubMed ID: 15246507
    [Abstract] [Full Text] [Related]

  • 14. Blood agar for susceptibility testing of Mycobacterium tuberculosis against first-line drugs.
    Coban AY, Cihan CC, Bilgin K, Uzun M, Akgunes A, Cetinkaya E, Durupinar B.
    Int J Tuberc Lung Dis; 2006 Apr; 10(4):450-3. PubMed ID: 16602412
    [Abstract] [Full Text] [Related]

  • 15. [In vitro susceptibilities of Mycobacterium avium and Mycobacterium intracellulare to various drugs].
    Tomioka H, Sato K, Saito H.
    Kekkaku; 1991 Jul; 66(7):489-92. PubMed ID: 1890791
    [Abstract] [Full Text] [Related]

  • 16. Antimycobacterial drugs.
    Heifets LB.
    Semin Respir Infect; 1994 Jun; 9(2):84-103. PubMed ID: 7973175
    [Abstract] [Full Text] [Related]

  • 17. High efficacy of clofazimine and its synergistic effect with amikacin against rapidly growing mycobacteria.
    Shen GH, Wu BD, Hu ST, Lin CF, Wu KM, Chen JH.
    Int J Antimicrob Agents; 2010 Apr; 35(4):400-4. PubMed ID: 20138481
    [Abstract] [Full Text] [Related]

  • 18. [Evaluation of a newly developed broth microdilution test method to determine minimum inhibitory concentrations (MICs) of antimicrobial agents for mycobacteria].
    Yamane N, Nakasone I, Saitoh H, Kaneda M, Shimojima M, Yamashita K, Toyoda K, Okazawa Y.
    Rinsho Byori; 1998 Jul; 46(7):719-27. PubMed ID: 9721542
    [Abstract] [Full Text] [Related]

  • 19. Nontuberculous mycobacterial skin infections: clinical and bacteriological studies.
    Mahaisavariya P, Chaiprasert A, Khemngern S, Manonukul J, Gengviniij N, Ubol PN, Pinitugsorn S.
    J Med Assoc Thai; 2003 Jan; 86(1):52-60. PubMed ID: 12678139
    [Abstract] [Full Text] [Related]

  • 20. In vitro activity of C-8-methoxy fluoroquinolones against mycobacteria when combined with anti-tuberculosis agents.
    Lu T, Drlica K.
    J Antimicrob Chemother; 2003 Dec; 52(6):1025-8. PubMed ID: 14613961
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.